Share Price and Basic Stock Data
Last Updated: February 14, 2026, 9:37 pm
| PEG Ratio | -2.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uniphos Enterprises Ltd operates in a niche sector, recording a market capitalization of ₹851 Cr. The company’s price per share stood at ₹121, with a P/E ratio of 42.9, indicating a relatively high valuation compared to its earnings. Historical revenue performance reveals a significant decline, with sales reported at ₹1 Cr in FY 2023, followed by a projected recovery to ₹51 Cr in FY 2024 and ₹112 Cr in FY 2025. However, quarterly data shows a concerning trend of zero sales from June 2023 through September 2023, suggesting operational challenges. The company’s ability to generate revenue has fluctuated dramatically, reflecting uncertainty in its business model and market demand. The trailing twelve months’ (TTM) revenue was reported at ₹84 Cr, underscoring the volatility in revenue generation. Overall, Uniphos Enterprises Ltd’s revenue trajectory poses questions about its operational efficiency and market positioning.
Profitability and Efficiency Metrics
Uniphos Enterprises Ltd’s profitability has been under pressure, evidenced by its operating profit margin (OPM) which recorded negative figures across recent periods. For instance, the OPM stood at -3% in FY 2025, reflecting challenges in managing costs relative to sales. The company’s net profit was reported at ₹19 Cr, translating to a minimal return on equity (ROE) of 0.01%. This low ROE indicates that the company is not effectively utilizing its equity base to generate profit, which is substantially below typical sector standards. The interest coverage ratio (ICR) was reported at 1.75x, indicating that the company’s earnings are just above the interest obligations, suggesting tight financial flexibility. Furthermore, the cash conversion cycle (CCC) was recorded at -0 days, which, while seemingly efficient, may reflect issues in reporting or operational effectiveness. Overall, the profitability metrics point towards a need for strategic operational improvements.
Balance Sheet Strength and Financial Ratios
The balance sheet of Uniphos Enterprises Ltd presents a mixed picture. The company reported total reserves of ₹2,831 Cr, with borrowings standing at a minimal ₹1 Cr, indicating a strong equity position and low debt levels. The price-to-book value (P/BV) ratio is notably low at 0.41x, suggesting that the stock might be undervalued relative to its net assets. However, the company’s return on capital employed (ROCE) was recorded at 0.06%, indicating ineffective use of capital to generate profits. Additionally, the current ratio was reported at 8.83, signifying robust liquidity and the ability to meet short-term obligations. Despite strong reserves, the overall financial ratios indicate challenges in translating these reserves into operational efficiency and profitability. The company must leverage its reserves to enhance revenue-generating capabilities and improve its financial performance.
Shareholding Pattern and Investor Confidence
Uniphos Enterprises Ltd’s shareholding pattern reflects a stable structure, with promoters holding 73.79% of the company, indicating strong control and commitment to the business. Foreign institutional investors (FIIs) accounted for 15.71% of the shareholding, while the public holds 10.50%. The number of shareholders has fluctuated, reaching 12,699 as of September 2025, which suggests a growing interest among retail investors. However, the high promoter stake, while stabilizing, may limit liquidity and the influence of minority shareholders. The consistent FII participation indicates a level of confidence in the long-term potential of the company, though the public’s relatively small stake could reflect caution among retail investors. The shareholding dynamics suggest a need for the company to enhance transparency and engagement with its broader shareholder base to foster trust and potentially attract more investors.
Outlook, Risks, and Final Insight
The outlook for Uniphos Enterprises Ltd hinges on its ability to stabilize revenue generation and improve profitability. Key strengths include a solid reserve base and minimal debt, which provide a cushion against operational volatility. However, significant risks loom, including its erratic sales performance and declining profitability metrics, which could deter investor confidence. The company must address operational inefficiencies and develop a robust strategy to enhance its market presence. Future scenarios may unfold based on its ability to pivot towards profitable operations or further decline if current trends persist. If Uniphos can capitalize on its reserves to innovate or expand, it may yet regain a strong market position. Conversely, failure to improve operational efficiency could lead to sustained financial underperformance, impacting shareholder value and market perception.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 107 Cr. | 27.9 | 587/20.5 | 1.05 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 3,040 Cr. | 188 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 45.2 Cr. | 3.54 | 7.43/2.70 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,047.79 Cr | 216.99 | 269.46 | 219.10 | 0.26% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 0 | 0 | 0 | 0 | 0 | 51 | 3 | 30 | 5 | 73 | 6 | 0 |
| Expenses | 2 | 1 | 1 | 1 | 1 | 1 | 52 | 4 | 31 | 6 | 74 | 7 | 1 |
| Operating Profit | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -1 | -2 | -1 | -1 |
| OPM % | -53% | -2% | -25% | -2% | -20% | -2% | -14% | ||||||
| Other Income | 40 | 1 | 1 | 1 | 40 | 1 | 1 | 1 | 5 | 0 | 0 | 0 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 39 | -0 | 0 | -0 | 39 | -0 | -0 | -0 | 4 | -2 | -2 | -1 | 23 |
| Tax % | 0% | 1,017% | -135% | 0% | 0% | 0% | 50% | 0% | 0% | -3% | 0% | 0% | 0% |
| Net Profit | 39 | -1 | 0 | -0 | 39 | -0 | -1 | -0 | 4 | -2 | -2 | -1 | 23 |
| EPS in Rs | 5.65 | -0.10 | 0.07 | -0.01 | 5.66 | -0.00 | -0.09 | -0.02 | 0.56 | -0.27 | -0.23 | -0.11 | 3.33 |
Last Updated: February 3, 2026, 6:16 pm
Below is a detailed analysis of the quarterly data for Uniphos Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 6.00 Cr..
- For Expenses, as of Sep 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Jun 2025) to 1.00 Cr., marking a decrease of 6.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -1.00 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value appears strong and on an upward trend. It has increased from -14.00% (Jun 2025) to 0.00%, marking an increase of 14.00%.
- For Other Income, as of Sep 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 24.00 Cr., marking an increase of 24.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 24.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 24.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.33. The value appears strong and on an upward trend. It has increased from -0.11 (Jun 2025) to 3.33, marking an increase of 3.44.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 84 |
| Expenses | 10 | 3 | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 4 | 54 | 115 | 88 |
| Operating Profit | -1 | -1 | -1 | -2 | -2 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | -5 |
| OPM % | -6% | -47% | -987% | -370% | -257% | -195% | -6% | -3% | -5% | ||||
| Other Income | 7 | 11 | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 25 |
| Interest | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | 19 |
| Tax % | 0% | 0% | 0% | 0% | 2% | 2% | 2% | -4% | -1% | 1% | 1% | -22% | |
| Net Profit | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 19 |
| EPS in Rs | -0.23 | 1.23 | 1.70 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.55 | 0.04 | 2.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 97% | 72% | 115% | 103% | 1,242% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 550.00% | 33.33% | -8.33% | 63.64% | 16.67% | -4.76% | 20.00% | 129.17% | -29.09% | 0.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -516.67% | -41.67% | 71.97% | -46.97% | -21.43% | 24.76% | 109.17% | -158.26% | 29.09% | -100.00% |
Uniphos Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 244% |
| 3 Years: | 350% |
| TTM: | 113% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -29% |
| 5 Years: | -58% |
| 3 Years: | -83% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 18% |
| 3 Years: | 5% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: January 7, 2026, 4:35 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 249 | 258 | 270 | 2,053 | 2,076 | 2,684 | 1,504 | 2,701 | 3,167 | 2,984 | 2,062 | 2,728 | 2,831 |
| Borrowings | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Liabilities | 7 | 0 | 0 | 0 | 0 | 0 | 1 | 57 | 121 | 98 | 2 | 100 | 117 |
| Total Liabilities | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
| Fixed Assets | 174 | 174 | 174 | 175 | 175 | 175 | 175 | 176 | 176 | 184 | 183 | 182 | 182 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 84 | 84 | 84 | 1,856 | 1,871 | 2,483 | 1,261 | 2,550 | 3,080 | 2,856 | 1,802 | 2,616 | 2,735 |
| Other Assets | 23 | 24 | 26 | 36 | 44 | 40 | 83 | 46 | 46 | 55 | 92 | 44 | 46 |
| Total Assets | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
Below is a detailed analysis of the balance sheet data for Uniphos Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,831.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,728.00 Cr. (Mar 2025) to 2,831.00 Cr., marking an increase of 103.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 117.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 17.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,962.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 182.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 182.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2,735.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 2,735.00 Cr., marking an increase of 119.00 Cr..
- For Other Assets, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,962.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
Notably, the Reserves (2,831.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.00 | -11.00 | -1.00 | -2.00 | -2.00 | -3.00 | -2.00 | -3.00 | -3.00 | -3.00 | -3.00 | -4.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Inventory Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Working Capital Days | -692 | -1,982 | 24,772 | 6,680 | 4,434 | 17 | -11 | -6 | ||||
| ROCE % | 2% | 3% | 4% | 1% | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 0% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Diluted EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Cash EPS (Rs.) | 0.14 | 5.67 | 5.73 | 7.86 | 3.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 373.37 | 277.58 | 410.17 | 436.48 | 369.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 394.22 | 298.43 | 431.02 | 457.33 | 390.35 |
| Dividend / Share (Rs.) | 0.50 | 5.70 | 6.50 | 5.65 | 3.40 |
| Revenue From Operations / Share (Rs.) | 16.03 | 7.28 | 0.21 | 0.17 | 0.11 |
| PBDIT / Share (Rs.) | 0.33 | 5.72 | 5.78 | 7.76 | 3.37 |
| PBIT / Share (Rs.) | 0.22 | 5.60 | 5.70 | 7.76 | 3.36 |
| PBT / Share (Rs.) | 0.03 | 5.60 | 5.70 | 7.76 | 3.36 |
| Net Profit / Share (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| PBDIT Margin (%) | 2.06 | 78.53 | 2732.78 | 4417.35 | 2813.99 |
| PBIT Margin (%) | 1.38 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| PBT Margin (%) | 0.20 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| Net Profit Margin (%) | 0.24 | 76.24 | 2664.95 | 4469.11 | 2936.36 |
| Return on Networth / Equity (%) | 0.01 | 2.00 | 1.37 | 1.79 | 0.95 |
| Return on Capital Employeed (%) | 0.05 | 1.87 | 1.28 | 1.63 | 0.84 |
| Return On Assets (%) | 0.00 | 1.85 | 1.26 | 1.65 | 0.88 |
| Asset Turnover Ratio (%) | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Current Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Quick Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Dividend Payout Ratio (NP) (%) | 14244.01 | 117.06 | 100.17 | 43.30 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3837.47 | 114.59 | 98.65 | 43.27 | 0.00 |
| Earning Retention Ratio (%) | -14144.01 | -17.06 | -0.17 | 56.70 | 0.00 |
| Cash Earning Retention Ratio (%) | -3737.47 | -14.59 | 1.35 | 56.73 | 0.00 |
| Interest Coverage Ratio (X) | 1.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1068.15 | 884.06 | 1038.32 | 913.70 | 586.13 |
| EV / Net Operating Revenue (X) | 9.58 | 17.46 | 705.43 | 747.83 | 703.89 |
| EV / EBITDA (X) | 464.68 | 22.23 | 25.81 | 16.93 | 25.01 |
| MarketCap / Net Operating Revenue (X) | 9.72 | 18.39 | 727.16 | 753.35 | 709.07 |
| Retention Ratios (%) | -14144.01 | -17.06 | -0.17 | 56.69 | 0.00 |
| Price / BV (X) | 0.41 | 0.48 | 0.37 | 0.30 | 0.22 |
| Price / Net Operating Revenue (X) | 9.72 | 18.39 | 727.32 | 753.70 | 709.87 |
| EarningsYield | 0.00 | 0.04 | 0.03 | 0.05 | 0.04 |
After reviewing the key financial ratios for Uniphos Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 3. It has decreased from 5.67 (Mar 24) to 0.14, marking a decrease of 5.53.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 373.37. It has increased from 277.58 (Mar 24) to 373.37, marking an increase of 95.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 394.22. It has increased from 298.43 (Mar 24) to 394.22, marking an increase of 95.79.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 5.70 (Mar 24) to 0.50, marking a decrease of 5.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.03. It has increased from 7.28 (Mar 24) to 16.03, marking an increase of 8.75.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 2. It has decreased from 5.72 (Mar 24) to 0.33, marking a decrease of 5.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.22, marking a decrease of 5.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.03, marking a decrease of 5.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For PBDIT Margin (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 10. It has decreased from 78.53 (Mar 24) to 2.06, marking a decrease of 76.47.
- For PBIT Margin (%), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 1.38, marking a decrease of 75.51.
- For PBT Margin (%), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 0.20, marking a decrease of 76.69.
- For Net Profit Margin (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 76.24 (Mar 24) to 0.24, marking a decrease of 76.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 15. It has decreased from 2.00 (Mar 24) to 0.01, marking a decrease of 1.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 10. It has decreased from 1.87 (Mar 24) to 0.05, marking a decrease of 1.82.
- For Return On Assets (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 1.85 (Mar 24) to 0.00, marking a decrease of 1.85.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 3. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Quick Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 2. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14,244.01. This value exceeds the healthy maximum of 50. It has increased from 117.06 (Mar 24) to 14,244.01, marking an increase of 14,126.95.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3,837.47. This value exceeds the healthy maximum of 50. It has increased from 114.59 (Mar 24) to 3,837.47, marking an increase of 3,722.88.
- For Earning Retention Ratio (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 40. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3,737.47. This value is below the healthy minimum of 40. It has decreased from -14.59 (Mar 24) to -3,737.47, marking a decrease of 3,722.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.75, marking an increase of 1.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.21, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,068.15. It has increased from 884.06 (Mar 24) to 1,068.15, marking an increase of 184.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.58. This value exceeds the healthy maximum of 3. It has decreased from 17.46 (Mar 24) to 9.58, marking a decrease of 7.88.
- For EV / EBITDA (X), as of Mar 25, the value is 464.68. This value exceeds the healthy maximum of 15. It has increased from 22.23 (Mar 24) to 464.68, marking an increase of 442.45.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For Retention Ratios (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 30. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.41, marking a decrease of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uniphos Enterprises Ltd:
- Net Profit Margin: 0.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.05% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.01% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 8.83
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 39.8 (Industry average Stock P/E: 269.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 11, G.I.D.C., Vapi, Valsad District Gujarat 396195 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Chandrasen Ashar | Chairman & Non-Exe.Director |
| Mrs. Sandra Rajnikant Shroff | Managing Director |
| Mrs. Meena Deepak Ved | Independent Director |
| Mr. Jaidev Rajnikant Shroff | Non Executive Director |
| Mr. Prasad Vasudev Paranjape | Independent Director |
| Mr. Suresh Balasubramaniam | Independent Director |
FAQ
What is the intrinsic value of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd's intrinsic value (as of 14 February 2026) is ₹1.06 which is 99.07% lower the current market price of ₹114.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹790 Cr. market cap, FY2025-2026 high/low of ₹173/100, reserves of ₹2,831 Cr, and liabilities of ₹2,962 Cr.
What is the Market Cap of Uniphos Enterprises Ltd?
The Market Cap of Uniphos Enterprises Ltd is 790 Cr..
What is the current Stock Price of Uniphos Enterprises Ltd as on 14 February 2026?
The current stock price of Uniphos Enterprises Ltd as on 14 February 2026 is ₹114.
What is the High / Low of Uniphos Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uniphos Enterprises Ltd stocks is ₹173/100.
What is the Stock P/E of Uniphos Enterprises Ltd?
The Stock P/E of Uniphos Enterprises Ltd is 39.8.
What is the Book Value of Uniphos Enterprises Ltd?
The Book Value of Uniphos Enterprises Ltd is 409.
What is the Dividend Yield of Uniphos Enterprises Ltd?
The Dividend Yield of Uniphos Enterprises Ltd is 0.44 %.
What is the ROCE of Uniphos Enterprises Ltd?
The ROCE of Uniphos Enterprises Ltd is 0.06 %.
What is the ROE of Uniphos Enterprises Ltd?
The ROE of Uniphos Enterprises Ltd is 0.01 %.
What is the Face Value of Uniphos Enterprises Ltd?
The Face Value of Uniphos Enterprises Ltd is 2.00.